Private Equity Firm Takes Public Company Private

We served as lead regulatory counsel to a private equity investment firm in its multi-billion dollar bid to take a publicly traded healthcare company private. Our team conducted regulatory due diligence and advised the private equity investment firm on the deal.

You Also May Be Interested In:

  • Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee

    We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company
  • Bass, Berry & Sims served as lead counsel to Tennessee Orthopedic Alliance (TOA) in obtaining a Certificate of Need (CON)...
    Client Type: Private Company
  • Lead counsel representing emergency department provider and other defendants in qui tam lawsuit alleging violation of licensure laws caused submission of false claims. District court dismissed allegations against the emergency department provider on grounds that alleged regulatory violation did not satisfy standard for FCA materiality set forth in Supreme Court’s Escobar decision. U.S. ex rel. Taylor v. Boyko, 2019 WL 2423283 (S.D. W. Va. Jun. 6, 2019).

    Bass, Berry & Sims served as lead counsel representing an emergency department provider and other defendants in a qui tam...